These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 28867602

  • 21. Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions.
    Pentikis HS, Adetoro N.
    Clin Pharmacol Drug Dev; 2018 Jun; 7(5):543-553. PubMed ID: 29125715
    [Abstract] [Full Text] [Related]

  • 22. [Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].
    Wang FM, Qian XD, Xu H, Yu HY.
    Zhonghua Yi Xue Za Zhi; 2008 Aug 12; 88(31):2201-3. PubMed ID: 19080672
    [Abstract] [Full Text] [Related]

  • 23. Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial Vaginosis: A Randomized Controlled Trial.
    Mauck C, Hillier SL, Gendreau J, Dart C, Chavoustie S, Sorkin-Wells V, Nicholson-Uhl C, Perez B, Jacobs M, Zack N, Friend D.
    Obstet Gynecol; 2022 Jun 01; 139(6):1092-1102. PubMed ID: 35675606
    [Abstract] [Full Text] [Related]

  • 24. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.
    Zeron Mullins M, Trouton KM.
    Trials; 2015 Jul 26; 16():315. PubMed ID: 26210791
    [Abstract] [Full Text] [Related]

  • 25. Vaginitis.
    Hainer BL, Gibson MV.
    Am Fam Physician; 2011 Apr 01; 83(7):807-15. PubMed ID: 21524046
    [Abstract] [Full Text] [Related]

  • 26. [Sucrose gel for treatment of bacterial vaginosis: a randomized, double-blind, multi-center, parallel-group, phase III clinical trial].
    Xiao BB, Zhang D, Chen R, Shi HR, Xin XR, Wang HL, Pang YC, Zhu SN, Yao C, Liao QP.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec 18; 47(6):925-32. PubMed ID: 26679652
    [Abstract] [Full Text] [Related]

  • 27. Thorough QT/QTc Evaluation of the Cardiac Safety of Secnidazole at Therapeutic and Supratherapeutic Doses in Healthy Individuals.
    Darpo B, Xue H, Adetoro N, Matthews BG, Pentikis HS.
    J Clin Pharmacol; 2018 Mar 18; 58(3):286-293. PubMed ID: 28967984
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis.
    Minozzi M, Gerli S, Di Renzo GC, Papaleo E, Ferrari A.
    Eur Rev Med Pharmacol Sci; 2008 Mar 18; 12(1):59-65. PubMed ID: 18401974
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial Vaginosis: A Randomized Clinical Trial.
    Raba G, Durkech A, Malík T, Bassfeld D, Grob P, Hurtado-Chong A, Fluomizin Study Group.
    JAMA Netw Open; 2024 May 01; 7(5):e248661. PubMed ID: 38696172
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis.
    Thulkar J, Kriplani A, Agarwal N.
    Indian J Pharmacol; 2012 Mar 01; 44(2):243-5. PubMed ID: 22529484
    [Abstract] [Full Text] [Related]

  • 35. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
    Verwijs MC, Agaba SK, Darby AC, van de Wijgert JHHM.
    Am J Obstet Gynecol; 2020 Feb 01; 222(2):157.e1-157.e13. PubMed ID: 31404542
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis.
    Schwebke JR, Carter BA, Waldbaum AS, Agnew KJ, Paull JRA, Price CF, Castellarnau A, McCloud P, Kinghorn GR.
    Eur J Obstet Gynecol Reprod Biol X; 2021 Apr 01; 10():100121. PubMed ID: 33537666
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.